Igf1 Mouse shRNA Plasmid (Locus ID 16000)
CAT#: TL501055
Igf1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | Igf1 Mouse shRNA Plasmid (Locus ID 16000) |
Locus ID | 16000 |
UniProt ID | P05017 |
Synonyms | C730016P09Rik; Igf; Igf-; Igf-1; Igf-I |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | Igf1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 16000). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | BC012409, NM_001111274, NM_001111275, NM_001111276, NM_010512, NM_184052, NM_001111274.1, NM_184052.1, NM_184052.2, NM_184052.3, NM_010512.1, NM_010512.2, NM_010512.3, NM_010512.4, NM_010512.5, NM_001111275.1, NM_001111275.2, NM_001111276.1 |
Summary | This gene encodes a member of the insulin-like growth factor (IGF) family of proteins that promote growth and development during fetal and postnatal life. This gene is predominantly expressed in the liver and the encoded protein undergoes proteolytic processing to generate a disulfide-linked mature polypeptide. Transgenic disruption of this gene in mice results in reduced postnatal survival and severe growth retardation. Mice lacking the encoded protein exhibit generalized organ hypoplasia including underdevelopment of the central nervous system and developmental defects in bone, muscle and reproductive systems. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate mature protein. [provided by RefSeq, Sep 2015] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Intracellular Insulin-like Growth Factor-I Induces Bcl-2 Expression in Airway Epithelial Cells 1
,null,
Journal of Immunology (Baltimore, Md. : 1950)
,PubMed ID 22461702
[Igf1]
|
Acute Inflammation Induces Insulin-like Growth Factor-1 to Mediate Bcl-2 and Muc5ac Expression in Airway Epithelial Cells
,null,
American Journal of Respiratory Cell and Molecular Biology
,PubMed ID 22878411
[Igf1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...